
ADMA Biologics, Inc.
USD7.76
+0.16 (+2.11%)
CEO
Adam S. Grossman
IPO Date
2013-10-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$7.53
Prev. Close
$7.60
Day Low
$7.46
Day High
$7.79
52W Low
$7.21
52W High
$22.37
Market Cap
$1.80B
Volume
2.81M
| 26 Mar 2026 |
| Cantor Fitzgerald |
| Overweight |
| Neutral |
| downgrade |
| 8 May 2025 | Raymond James | Strong Buy | Strong Buy | maintain |
| 4 Mar 2025 | Cantor Fitzgerald | Overweight | Overweight | maintain |
| 8 Nov 2024 | HC Wainwright & Co. | Buy | Buy | maintain |
| 8 Nov 2024 | Raymond James | Strong Buy | Strong Buy | maintain |
| 14 Oct 2024 | HC Wainwright & Co. | Buy | Buy | maintain |
| 20 Sept 2024 | Cantor Fitzgerald | Overweight | Overweight | maintain |